Recombinant adiponectin administration is sufficient to improve glucose, lipid, and insulin plasma levels as well as insulin receptor expression and liver steatosis in high fat diet-induced obesity mice treated with streptozotocin [62]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.